title: Is adjuvant chemotherapy useful for women with luminal a breast cancer?
authors.affiliation: International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia.
authors.forename: Alan S
authors.initials: AS
authors.lastname: Coates
authors.forename: Marco
authors.initials: M
authors.lastname: Colleoni
authors.forename: Aron
authors.initials: A
authors.lastname: Goldhirsch
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D042241:Early Diagnosis; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D007391:International Cooperation; D015412:Mastectomy, Segmental / Q000379:methods; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016019:Survival Analysis; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D013629:Tamoxifen